Table 2. Solicited Adverse Events (AE) after Influenza A (H7N7) Vaccinatons.
No. (%) with ≥One AE in Category | |||||||||
Dose 1 | Dose 2 | ||||||||
Adverse Events | Dosage1 (µg HA) | No.2 | Mild | Mod | Severe | No.2 | Mild | Mod | Severe |
Systemic | 0 | 25 | 5 (20) | 3 (12) | 0 | 22 | 5 (23) | 1 (5) | 0 |
7.5 | 25 | 10 (40) | 1 (4) | 0 | 24 | 1 (4) | 1 (4) | 0 | |
15 | 25 | 9 (36) | 2 (8) | 0 | 24 | 5 (21) | 1 (4) | 0 | |
45 | 25 | 5 (20) | 2 (8) | 0 | 23 | 3 (13) | 0 (0) | 0 | |
90 | 25 | 4 (16) | 6 (24) | 0 | 25 | 4 (16) | 1 (4) | 0 | |
Local | 0 | 25 | 13 (52) | 0 (0) | 0 | 22 | 12 (55) | 0 (0) | 0 |
7.5 | 25 | 15 (60) | 0 (0) | 0 | 24 | 14 (58) | 0 (0) | 0 | |
15 | 25 | 11 (44) | 2 (8) | 0 | 24 | 17 (71) | 1 (4) | 0 | |
45 | 25 | 14 (56) | 1 (4) | 0 | 23 | 15 (65) | 3 (13) | 0 | |
90 | 25 | 14 (56) | 3 (12) | 0 | 25 | 13 (52) | 3 (12) | 0 |
As determined in single radial immunodiffusion assays.
Number subjects evaluated.